360-53-2,
Methyl perfluoroisobutenyl ether,
Heptafluoroisobutylene methyl ether,
ETHER, METHYL HEPTAFLUOROISOBUTENYL,
1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)prop-1-ene,
1-Propene, 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-,
1,1,1,3-tetrafluoro-2-(trifluoromethyl)-4-oxapent-2-ene,
BRN 1787514,
1-methoxy(perfluoro-2-methyl-1-propene),
1-Methoxy-(perfluoro-2-methyl-1-propene),
FSDLLONBRLBIBL-UHFFFAOYSA-N,
Ether, methyl 1,3,3,3-tetrafluoro-2-(trifluoromethyl)propenyl,
1-Propene,1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-,
AC1L1TK7,
SCHEMBL154401,
DTXSID5073167,
1-methoxyheptafluoro-1-isobutene,
CTK4H5809,
heptafluoroisobutenyl methyl ether,
PC5060D,
ZINC2040738,
ZX-AP012454,
ACM360532,
MFCD00054679,
SBB094584,
AKOS015852384,
FCH1322955,
1-Methoxyperfluoro(2-methylprop-1-ene),
CJ-32418,
LS-67865,
TR-014832,
FT-0607997,
A823103,
Ether, methyl tetrafluoro-2-(trifluoromethyl)propenyl,
I14-29179,
1,3,3,3-Tetrafluoro-2-trifluoromethyl-1-methoxy-1-propene,
1,3,3,3-Tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene,
1-methoxy-1,3,3,3-tetrafluoro-2-(trifluoromethyl)prop-1-ene,
1-Propene, 1-methoxy-2-trifluoromethyl-1,3,3,3-tetrafluoro-,
Ether, methyl tetrafluoro-2-(trifluoromethyl)propenyl (8CI),
1,3,3,3-Tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene #,
1,3,3,3-tetrakis(fluoranyl)-1-methoxy-2-(trifluoromethyl)prop-1-ene,
1-Propene, 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)- (9CI),
GSK-3b inhibitor II,
CID9672,
C5-H3-F7-O,
4-01-00-03454 (Beilstein Handbook Reference),
478482-75-6,